Latest Insider Transactions at Silk Road Medical Inc (SILK)
This section provides a real-time view of insider transactions for Silk Road Medical Inc (SILK). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Silk Road Medical Inc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Silk Road Medical Inc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 15
2023
|
Andrew S. Davis Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
121,519
+34.47%
|
-
|
|
Aug 17
2023
|
Kevin M Klemz EVP/Chief Legal Officer/Sec. |
SELL
Open market or private sale
|
Direct |
1,539
-3.82%
|
$30,780
$20.11 P/Share
|
|
Aug 03
2023
|
Andrew S. Davis Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
6,587
-5.67%
|
$144,914
$22.13 P/Share
|
|
Jul 28
2023
|
Lucas W. Buchanan COO & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,643
+2.19%
|
$96,430
$10.8 P/Share
|
|
Jul 20
2023
|
Marie L. Jones VP, Finance and CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+4.0%
|
$12,000
$6.11 P/Share
|
|
Jul 11
2023
|
Erica J. Rogers President and CEO |
SELL
Open market or private sale
|
Direct |
1,000
-0.37%
|
$31,000
$31.56 P/Share
|
|
Jul 11
2023
|
Erica J. Rogers President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+0.37%
|
$1,000
$1.6 P/Share
|
|
Jul 06
2023
|
Andrew S. Davis Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
69
-0.06%
|
$2,070
$30.79 P/Share
|
|
Jun 21
2023
|
Elizabeth H Weatherman |
BUY
Grant, award, or other acquisition
|
Direct |
4,691
+3.05%
|
-
|
|
Jun 21
2023
|
Tony M. Chou |
BUY
Grant, award, or other acquisition
|
Direct |
4,691
+5.58%
|
-
|
|
Jun 21
2023
|
Donald Zurbay |
BUY
Grant, award, or other acquisition
|
Direct |
4,691
+41.0%
|
-
|
|
Jun 21
2023
|
Tanisha Carino |
BUY
Grant, award, or other acquisition
|
Direct |
4,691
+45.86%
|
-
|
|
Jun 21
2023
|
Jack W Lasersohn |
BUY
Grant, award, or other acquisition
|
Direct |
4,691
+30.13%
|
-
|
|
Jun 21
2023
|
Rick D Anderson |
BUY
Grant, award, or other acquisition
|
Direct |
4,691
+43.44%
|
-
|
|
Jun 21
2023
|
Kevin J. Ballinger |
BUY
Grant, award, or other acquisition
|
Direct |
4,691
+43.44%
|
-
|
|
Jun 12
2023
|
Erica J. Rogers President and CEO |
SELL
Open market or private sale
|
Direct |
1,000
-0.37%
|
$32,000
$32.13 P/Share
|
|
Jun 12
2023
|
Erica J. Rogers President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+0.37%
|
$1,000
$1.6 P/Share
|
|
May 19
2023
|
Andrew S. Davis Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
507
+0.43%
|
$13,182
$26.17 P/Share
|
|
May 19
2023
|
Lucas W. Buchanan COO & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
507
+0.25%
|
$13,182
$26.17 P/Share
|
|
May 19
2023
|
Marie L. Jones VP, Finance and CAO |
BUY
Grant, award, or other acquisition
|
Direct |
506
+1.09%
|
$13,156
$26.17 P/Share
|
|
May 19
2023
|
Erica J. Rogers President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
507
+0.19%
|
$13,182
$26.17 P/Share
|
|
May 11
2023
|
Erica J. Rogers President and CEO |
SELL
Open market or private sale
|
Direct |
3,000
-0.55%
|
$105,000
$35.51 P/Share
|
|
May 11
2023
|
Erica J. Rogers President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+0.55%
|
$3,000
$1.6 P/Share
|
|
May 01
2023
|
Andrew S. Davis Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
6,753
-1.4%
|
$297,132
$44.51 P/Share
|
|
May 01
2023
|
Andrew S. Davis Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,753
+1.37%
|
$54,024
$8.89 P/Share
|
|
Apr 17
2023
|
Elizabeth H Weatherman |
SELL
Open market or private sale
|
Direct |
5,000
-3.35%
|
$205,000
$41.91 P/Share
|
|
Apr 11
2023
|
Erica J. Rogers President and CEO |
SELL
Open market or private sale
|
Direct |
6,000
-2.18%
|
$234,000
$39.77 P/Share
|
|
Apr 11
2023
|
Erica J. Rogers President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+2.13%
|
$6,000
$1.6 P/Share
|
|
Apr 03
2023
|
Andrew S. Davis Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
6,753
-1.86%
|
$263,367
$39.42 P/Share
|
|
Apr 03
2023
|
Andrew S. Davis Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,753
+1.8%
|
$33,765
$5.19 P/Share
|
|
Mar 15
2023
|
Elizabeth H Weatherman |
SELL
Open market or private sale
|
Direct |
5,000
-3.24%
|
$205,000
$41.91 P/Share
|
|
Mar 13
2023
|
Erica J. Rogers President and CEO |
SELL
Open market or private sale
|
Direct |
6,000
-2.18%
|
$252,000
$42.23 P/Share
|
|
Mar 13
2023
|
Erica J. Rogers President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+2.13%
|
$6,000
$1.6 P/Share
|
|
Mar 06
2023
|
Richard Ruedy EVPClin&Reg.Affairs&QA |
SELL
Open market or private sale
|
Direct |
2,373
-1.6%
|
$111,531
$47.73 P/Share
|
|
Mar 06
2023
|
Andrew S. Davis Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
3,868
-3.24%
|
$181,796
$47.74 P/Share
|
|
Mar 03
2023
|
Lucas W. Buchanan COO & CFO |
SELL
Open market or private sale
|
Direct |
9,918
-4.6%
|
$466,146
$47.11 P/Share
|
|
Mar 03
2023
|
Erica J. Rogers President and CEO |
SELL
Open market or private sale
|
Direct |
18,043
-6.28%
|
$848,021
$47.1 P/Share
|
|
Mar 02
2023
|
Richard Ruedy EVPClin&Reg.Affairs&QA |
BUY
Grant, award, or other acquisition
|
Direct |
13,341
+8.28%
|
-
|
|
Mar 02
2023
|
Lucas W. Buchanan COO & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
26,682
+11.02%
|
-
|
|
Mar 02
2023
|
Kevin M Klemz EVP/Chief Legal Officer/Sec. |
BUY
Grant, award, or other acquisition
|
Direct |
20,011
+33.16%
|
-
|
|
Mar 02
2023
|
Andrew S. Davis Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,346
+15.15%
|
-
|
|
Mar 02
2023
|
Erica J. Rogers President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
40,976
+12.49%
|
-
|
|
Mar 01
2023
|
Andrew S. Davis Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
6,753
-3.26%
|
$324,144
$48.02 P/Share
|
|
Mar 01
2023
|
Andrew S. Davis Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,753
+3.11%
|
$27,012
$4.73 P/Share
|
|
Feb 15
2023
|
Elizabeth H Weatherman |
SELL
Open market or private sale
|
Direct |
5,000
-3.14%
|
$245,000
$49.86 P/Share
|
|
Feb 13
2023
|
Erica J. Rogers President and CEO |
SELL
Open market or private sale
|
Direct |
6,000
-2.38%
|
$300,000
$50.94 P/Share
|
|
Feb 13
2023
|
Erica J. Rogers President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+2.32%
|
$6,000
$1.6 P/Share
|
|
Feb 01
2023
|
Andrew S. Davis Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
6,753
-6.43%
|
$364,662
$54.05 P/Share
|
|
Feb 01
2023
|
Andrew S. Davis Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,753
+6.05%
|
$27,012
$4.73 P/Share
|
|
Feb 01
2023
|
Tony M. Chou |
SELL
Open market or private sale
|
Direct |
13,008
-14.66%
|
$715,440
$55.0 P/Share
|